MGRO (MGRO) News
Follow MGRO (MGRO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 5 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
MustGrow appoints Tyler Reinheimer as Director, Finance
MustGrow Biologics Corp. appointed Tyler Reinheimer, CPA, as Director, Finance. The board also approved a grant of deferred share units (DSUs), per the company’s announcement.
EQUITY | Sep 04, 2026, 11:06 AM UTC
L
MGRO: Sales up 46% year-over-year; margin recovery expected as manufacturing improves
MGRO: Sales up 46% year-over-year; margin recovery expected as manufacturing improves
EQUITY | Aug 31, 2026, 09:16 PM UTC
L
MGRO: TerraSante™ sales surged 46% year-over-year, with margins set to improve as manufacturing scales
MGRO: TerraSante™ sales surged 46% year-over-year, with margins set to improve as manufacturing scales
EQUITY | Aug 31, 2026, 08:50 PM UTC
L
MGRO reports $1.4M licensing revenue and returns to profit
MGRO said it achieved $1.4M licensing revenue and returned to profit, citing a strong outlook despite lower sales.
EARNINGS | Aug 27, 2026, 09:27 PM UTC
L
MustGrow announces second-quarter 2026 financial results
MustGrow said it has reported second-quarter 2026 financial results.
EARNINGS | Aug 27, 2026, 09:06 PM UTC